Keurig Dr Pepper (NASDAQ:KDP) Price Target Cut to $37.00

Keurig Dr Pepper (NASDAQ:KDP) had its price objective reduced by Barclays from $38.00 to $37.00 in a report released on Friday morning, Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts have also recently issued reports about the company. UBS Group lifted their price target on Keurig Dr Pepper from $39.00 to $40.00 and gave the company a buy rating in a research report on Monday, June 10th. BNP Paribas started coverage on shares of Keurig Dr Pepper in a report on Monday, June 24th. They set a neutral rating and a $36.00 target price for the company. JPMorgan Chase & Co. lowered their price target on shares of Keurig Dr Pepper from $37.00 to $36.00 and set an overweight rating on the stock in a report on Wednesday, July 10th. Jefferies Financial Group dropped their price target on shares of Keurig Dr Pepper from $37.00 to $35.00 and set a buy rating on the stock in a research report on Wednesday, March 27th. Finally, Wells Fargo & Company upped their price objective on shares of Keurig Dr Pepper from $39.00 to $41.00 and gave the stock an overweight rating in a research report on Wednesday, June 5th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of Moderate Buy and a consensus target price of $36.50.

Keurig Dr Pepper Stock Down 0.5 %

NASDAQ:KDP opened at $32.98 on Friday. The firm has a market capitalization of $44.71 billion, a P/E ratio of 21.28, a PEG ratio of 2.55 and a beta of 0.62. The company’s fifty day moving average price is $33.71 and its 200-day moving average price is $32.07. Keurig Dr Pepper has a 1-year low of $27.66 and a 1-year high of $35.00. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.51 and a quick ratio of 0.34.

Keurig Dr Pepper (NASDAQ:KDP) last announced its quarterly earnings results on Thursday, April 25th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.41 billion. Keurig Dr Pepper had a return on equity of 10.18% and a net margin of 14.52%. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period last year, the firm earned $0.34 EPS. As a group, equities research analysts anticipate that Keurig Dr Pepper will post 1.92 EPS for the current year.

Keurig Dr Pepper Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were issued a dividend of $0.215 per share. The ex-dividend date was Friday, June 28th. This represents a $0.86 dividend on an annualized basis and a dividend yield of 2.61%. Keurig Dr Pepper’s payout ratio is currently 55.48%.

Insider Activity

In other Keurig Dr Pepper news, insider Matthew Andrew Archambault sold 8,000 shares of Keurig Dr Pepper stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $34.19, for a total transaction of $273,520.00. Following the sale, the insider now owns 12,565 shares of the company’s stock, valued at approximately $429,597.35. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Keurig Dr Pepper news, insider Matthew Andrew Archambault sold 8,000 shares of the stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $34.19, for a total value of $273,520.00. Following the completion of the sale, the insider now owns 12,565 shares in the company, valued at approximately $429,597.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Patrick Minogue sold 17,293 shares of the business’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $33.59, for a total value of $580,871.87. Following the transaction, the insider now owns 67,103 shares in the company, valued at $2,253,989.77. The disclosure for this sale can be found here. Insiders have sold a total of 81,520 shares of company stock worth $2,750,739 over the last quarter. 1.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Keurig Dr Pepper

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Capital World Investors grew its stake in shares of Keurig Dr Pepper by 14.6% in the 4th quarter. Capital World Investors now owns 108,032,566 shares of the company’s stock valued at $3,599,652,000 after buying an additional 13,738,345 shares during the period. Price T Rowe Associates Inc. MD grew its position in Keurig Dr Pepper by 107.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 23,654,577 shares of the company’s stock worth $725,487,000 after acquiring an additional 12,259,471 shares during the period. Norges Bank purchased a new position in Keurig Dr Pepper in the fourth quarter worth approximately $317,979,000. Vanguard Group Inc. increased its stake in Keurig Dr Pepper by 9.4% during the first quarter. Vanguard Group Inc. now owns 90,840,391 shares of the company’s stock worth $2,786,075,000 after acquiring an additional 7,825,418 shares during the last quarter. Finally, Pathstone Holdings LLC purchased a new stake in Keurig Dr Pepper in the fourth quarter valued at $105,569,000. 85.23% of the stock is owned by institutional investors and hedge funds.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.